Indoco Remedies Stock Screener | Share Price & Fundamental Analysis
INDOCO
Pharmaceuticals
Screen Indoco Remedies share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹225.02
▼
-4.01 (-1.75%)
Share Price BSE
₹224.75
▼
-5.10 (-2.22%)
Market Cap
₹2,116.35 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.23
EPS (TTM)
₹-8.46
Dividend Yield
0.08%
Debt to Equity
0.78
52W High
₹341.00
52W Low
₹196.47
Operating Margin
-2.00%
Profit Margin
-10.62%
Revenue (TTM)
₹386.00
EBITDA
₹-5.00
Net Income
₹-41.00
Total Assets
₹2,430.00
Total Equity
₹1,018.00
Indoco Remedies Share Price History - Stock Screener Chart
Screen INDOCO historical share price movements with interactive charts. Analyze price trends and patterns.
Indoco Remedies Company Profile - Fundamental Screener
Screen Indoco Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDOCO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE873D01024
Indoco Remedies Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen INDOCO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,430 | 2,145 | 1,658 | 1,486 | 1,315 | 1,272 | 1,258 | 1,238 | 1,197 | 941 |
| Current Assets | 1,001 | 955 | 814 | 774 | 623 | 563 | 538 | 539 | 572 | 465 |
| Fixed Assets | 997 | 954 | 678 | 555 | 570 | 590 | 468 | 489 | 440 | 374 |
| Liabilities | ||||||||||
| Total Liabilities | 2,430 | 2,145 | 1,658 | 1,486 | 1,315 | 1,272 | 1,258 | 1,238 | 1,197 | 941 |
| Current Liabilities | 604 | 422 | 205 | 157 | 139 | 133 | 152 | 146 | 155 | 61 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,018 | 1,111 | 1,028 | 905 | 769 | 680 | 661 | 675 | 651 | 577 |
| Share Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves & Surplus | 1,004 | 1,092 | 1,010 | 886 | 751 | 661 | 642 | 657 | 633 | 558 |
Screen INDOCO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 386 | 433 | 473 | 462 | 425 | 432 | 404 | 429 | 417 | 478 | 461 | 401 | 396 | 405 | 412 |
| Expenses | 391 | 422 | 442 | 401 | 384 | 392 | 399 | 363 | 365 | 410 | 405 | 329 | 337 | 345 | 337 |
| EBITDA | -5 | 10 | 30 | 61 | 42 | 40 | 6 | 66 | 52 | 68 | 56 | 72 | 60 | 60 | 74 |
| Operating Profit % | -2.00% | 2.00% | 6.00% | 9.00% | 10.00% | 9.00% | 1.00% | 15.00% | 12.00% | 13.00% | 12.00% | 18.00% | 15.00% | 15.00% | 18.00% |
| Depreciation | 29 | 30 | 32 | 26 | 28 | 29 | 29 | 18 | 20 | 21 | 24 | 18 | 20 | 16 | 17 |
| Interest | 18 | 26 | 25 | 12 | 14 | 18 | 16 | 9 | 8 | 8 | 10 | 3 | 4 | 5 | 7 |
| Profit Before Tax | -46 | -37 | -14 | 33 | 7 | -5 | -31 | 39 | 34 | 46 | 23 | 60 | 48 | 67 | 38 |
| Tax | -4 | 0 | -4 | 11 | 5 | 5 | -3 | 13 | 10 | 11 | 7 | 19 | 10 | 18 | 10 |
| Net Profit | -41 | -36 | -9 | 22 | 2 | -10 | -28 | 26 | 24 | 35 | 16 | 41 | 39 | 50 | 28 |
| EPS | -4.48 | -3.94 | -1.00 | 2.39 | 0.20 | -1.09 | -3.08 | 2.80 | 2.62 | 3.82 | 1.69 | 4.39 | 4.19 | 5.40 | 3.05 |
Indoco Remedies Cash Flow Screener - Liquidity Fundamentals
Screen INDOCO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 95 | 155 | 179 | 174 | 82 | 123 | 132 | 123 | 89 | 112 |
| Investing Activities | -339 | -432 | -208 | -121 | -67 | -56 | -104 | -135 | -171 | -111 |
| Financing Activities | 241 | 280 | 23 | -44 | -30 | -64 | -16 | -39 | 132 | -2 |
| Net Cash Flow | -3 | 4 | -7 | 8 | -14 | 3 | 12 | -52 | 50 | 0 |
Screen INDOCO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 58.90% | 58.90% | 58.90% | 58.72% | 58.75% | 58.75% | 58.80% | 58.69% |
| FII Holding | 1.24% | 1.22% | 1.25% | 1.91% | 1.47% | 1.70% | 1.25% | 0.12% |
| DII Holding | 18.75% | 18.96% | 18.16% | 19.41% | 18.67% | 18.24% | 18.90% | 17.29% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.99% | 15.79% | 16.40% | 15.33% | 16.29% | 16.30% | 16.07% | 16.48% |
| Other Holding | 5.12% | 5.14% | 5.29% | 4.62% | 4.81% | 5.01% | 4.99% | 7.42% |
| Shareholder Count | 34,497 | 33,129 | 33,319 | 33,201 | 34,511 | 34,416 | 34,676 | 34,731 |
Indoco Remedies Dividend Screener - Share Yield Analysis
Screen INDOCO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.20 | 0.09% |
| 2024-March | ₹1.50 | 0.64% |
| 2023-March | ₹2.25 | 0.68% |
| 2022-March | ₹2.25 | 0.69% |
| 2021-March | ₹1.50 | 0.40% |
| 2020-March | ₹0.30 | 0.10% |
| 2019-March | ₹0.30 | 0.14% |
| 2018-March | ₹1.00 | 0.49% |
| 2017-March | ₹1.60 | 0.75% |
Indoco Remedies Index Membership - Market Screener Classification
Screen INDOCO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Indoco Remedies Market Events Screener - Corporate Actions
Screen INDOCO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.20 /share | 8.04% | ||
| Dividend | ₹ 0.75 /share | 8.37% | ||
| Dividend | ₹ 1.50 /share | 10.13% | ||
| Dividend | ₹ 2.25 /share | 2.59% | ||
| Dividend | ₹ 1.50 /share | 12.85% | ||
| Annual General Meeting | NA | 0.00% | ||
| Dividend | ₹ 1.50 /share | 31.90% | ||
| Annual General Meeting | NA | -5.74% | ||
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -7.97% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | -4.86% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 4.17% |
| 2025-01-21 | 2025-01-21 | Quarterly Result Announcement | NA | 2.60% |
| 2024-10-24 | 2024-10-24 | Quarterly Result Announcement | NA | -4.96% |
Indoco Remedies Competitors Screener - Peer Comparison
Screen INDOCO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 413,333 | 39.37 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 169,103 | 67.76 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 131,070 | 60.85 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,537 | 22.30 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,204 | 18.24 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 95,786 | 22.10 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 91,980 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 90,536 | 50.34 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 70,143 | 20.25 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 66,167 | 27.11 | 13,458 | 3.70% | 2,216 | 38.49 |
Indoco Remedies Company Announcements - News Screener
Screen INDOCO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-06 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-06 | Closure of Trading Window | View |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-19 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-15 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-28 | Retirement Of Senior Management Personnel | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-18 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-18 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-06 | Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-06 | Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th November 2025 | View |
| 2025-10-29 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Corporate Guarantee For Warren Remedies Private Limited Wholly Owned Subsidiary Of The Company | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |